Company profile

BYSI stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

30 Apr 20
5 Jun 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 0
Net income -15.06M -9.82M -7.62M -7.83M
Diluted EPS -0.54 -0.37 -0.32 -0.32
Operating income -15.29M -9.7M -7.35M -7.97M
Net change in cash 11.26M 24M -1.29M -1.93M
Cash on hand 35.93M 24.68M 674K 1.96M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 0 0 0 0
Net income -40.33M -57.47M -96.39M -12.55M
Diluted EPS -1.55 -2.42 -4.4 -0.75
Operating income -40.31M -57.55M -97.98M -12.37M
Net change in cash 32.04M -23.59M 15.79M 866K
Cash on hand 35.93M 3.89M 27.48M 11.69M

Financial data from company earnings reports

6.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 36 37 -2.7%
Opened positions 5 6 -16.7%
Closed positions 6 3 +100.0%
Increased positions 13 22 -40.9%
Reduced positions 13 3 +333.3%
13F shares
Current Prev Q Change
Total value 74.39M 57.24M +30.0%
Total shares 1.84M 1.87M -1.8%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
BLK BlackRock 689.28K $8.83M +3.0%
STT State Street 206.34K $2.64M +4.6%
NTRS Northern Trust 158.38K $2.03M +3.9%
FOSUY Fosun International 155.56K $1.99M -13.1%
GS Goldman Sachs 96.49K $1.24M +1.3%
Geode Capital Management 93.72K $1.2M +13.8%
Jacobs Levy Equity Management 61.21K $784K +3.8%
Vanguard 46.45K $595K -1.2%
Russell Investments 36.87K $471K NEW
Tanaka Capital Management 34.72K $445K -20.1%
Largest transactions
Shares Bought/sold Change
Alyeska Investment 0 -50.18K EXIT
Russell Investments 36.87K +36.87K NEW
FOSUY Fosun International 155.56K -23.36K -13.1%
Moore Capital Management 20K +20K NEW
BLK BlackRock 689.28K +19.93K +3.0%
Squarepoint Ops 0 -19.43K EXIT
MS Morgan Stanley 13.43K -16.71K -55.4%
Parametric Portfolio Associates 0 -11.91K EXIT
Geode Capital Management 93.72K +11.39K +13.8%
Alliancebernstein 10.9K +10.9K NEW

Financial report summary

?
Competition
MylanAmgenMylanMylanMylan
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: AccuraGen, Adjunct, AEs, aforesaid, AgreementSM, Anderson, Aon, Apexigen, Appendix, Ariagen, ATM, bacteremia, Blair, Bloomington, breakthrough, Centre, Chem, Chugai, Circuit, collateralized, compliant, consecutive, Cui, curb, customary, Daniel, Decheng, downgrading, dramatic, Efung, embody, Encodia, Endogena, exploratory, fluid, forthcoming, franchise, Fujisawa, Fulphila, GP, haptoglobin, Hoosier, implicit, index, Indiana, infection, innate, instigating, intrusion, justified, MD, movement, Mylan, Nanjing, Nimble, Northern, Omniome, outbreak, owed, pandemic, peer, persistency, persistent, Pharmacy, preemptive, premise, prepaid, prophylactical, prophylactically, RDI, readjustment, readout, reiterate, renamed, republished, residual, rolling, ROU, run, Saint, Sandoz, Searle, SEED, Sequencing, shift, simplification, simulating, smooth, speed, SRA, strain, surfaced, Syntex, TEEWIN, therewith, timeline, Udenyca, unconstitutional, underwritten, undiscounted, unease, uniform, unincorporated, upheld, Ventana, widespread, William, WindMI, WindMIL, worsen, worst, Xiangmin, Zabrowski, Ziextenzo
Removed: amounted, Brand, breath, BSIPO, calling, commensurate, Diego, entirety, gastric, Genetech, hub, inconvenience, Kobi, leasable, lessee, measureable, MGR, mutual, recurring, remediate, Renshaw, retired, Rodman, Room, San, Sethna, subscription, Tarceva, underwriter, Wainwright

Proxies

No filings